Cross-protection against challenge by intravenous<i>Escherichia coli</i>verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid
Kerstin U. Ludwig(University Hospital Bonn), M Petrić(University of Toronto), Corey Smith(QIMR Berghofer Medical Research Institute), Mohamed A. Karmali
Cited by 19
Related Papers
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
|Journal of Clinical Pathology|1984|261
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses
|Proceedings of the National Academy of Sciences|2004|235
BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies
|Clinical Microbiology Reviews|2017|226